美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
55513-479-02	55513-479	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	40 mg/.4mL	2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE
55513-480-01	55513-480	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	80 mg/.8mL	1 SYRINGE in 1 CARTON (55513-480-01) / .8 mL in 1 SYRINGE
55513-400-01	55513-400	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	40 mg/.8mL	1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE
55513-400-02	55513-400	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	40 mg/.8mL	2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE
55513-400-91	55513-400	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	40 mg/.8mL	1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE
55513-480-02	55513-480	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	80 mg/.8mL	2 SYRINGE in 1 CARTON (55513-480-02) / .8 mL in 1 SYRINGE
55513-482-02	55513-482	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	40 mg/.4mL	2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE
55513-481-01	55513-481	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	80 mg/.8mL	1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE
55513-481-02	55513-481	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	80 mg/.8mL	2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE
55513-482-01	55513-482	HUMAN PRESCRIPTION DRUG	AMJEVITA	adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814	N/A	BLA	BLA761024	Amgen, Inc	ADALIMUMAB	40 mg/.4mL	1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE